Add BrightSurf on Google Email

Science News Archive April 2018 - Page 21


Page 21 of 42

A graphene roll-out

Researchers at MIT have developed a continuous manufacturing process to produce long strips of high-quality graphene. The team's results are the first demonstration of an industrial, scalable method for manufacturing high-quality graphene suitable for membrane applications.

SourceMassachusetts Institute of Technology·JournalACS Applied Materials & Interfaces·DateApr 17, 2018

The enzyme designers

The study reveals that a slight change in the substrate can practically stop an enzyme reaction. Computational design of a new variant was successfully produced and tested, demonstrating the method's accuracy and potential for future research.

SourceTechnical University of Munich (TUM)·JournalNature Communications·DateApr 17, 2018

A new Listeria species from Costa Rica identified

A new bacterial species, Listeria costaricensis, has been identified in Costa Rica, increasing the knowledge of Listeria's pathogenic potential. The discovery was made through a three-year research project that sampled water from an industrial drainage area, revealing the biodiversity of Costa Rican soils.

SourceInstitut Pasteur·JournalINTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY·DateApr 17, 2018

Carbon dioxide as a raw material

Scientists at Ruhr-University Bochum successfully converted CO2 into an alcohol through a two-step reaction, facilitated by copper and rhodium catalysts. The process achieved a 40% recycling rate for the base, paving the way for industrial-scale applications.

SourceRuhr-University Bochum·JournalChemistry - A European Journal·DateApr 17, 2018

Safety concerns over tungsten

A recent study published in Communications Chemistry found that tungsten accumulates in specific regions of the bone, particularly in bone marrow and cancellous bone tissue. This accumulation raises concerns over the element's safety for human exposure, especially among young individuals.

SourceMcGill University·JournalCommunications Chemistry·DateApr 17, 2018

Timing is everything: Researchers describe genetic clockwork in germ cell development

Geneticists at Martin Luther University Halle-Wittenberg deciphered a central signalling pathway that encodes and controls the synchronisation of multiple processes during germ cell development in C. elegans. This process involves RNA-binding proteins and a MAP kinase signalling pathway, optimising germ cell production.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalProceedings of the National Academy of Sciences·DateApr 16, 2018

Articles provide updated guidance to authors submitting to the British Journal of Pharmacology

The British Journal of Pharmacology has published updated guidance for authors on designing experiments, analyzing data, and presenting results. The editorials aim to improve reproducibility and transparency in preclinical research by providing approaches to data presentation and checklists for immunoblotting and immunohistochemistry.

SourceWiley·JournalBritish Journal of Pharmacology·DateApr 16, 2018

Self-regulation in children, adolescents

A systematic review of 49 randomized trials involving 23,098 participants found that various self-regulation interventions were effective in promoting emotional control, social skills, and learning. The review suggests that these programs can help maintain health and well-being throughout life.

SourceJAMA Network·JournalJAMA Pediatrics·DateApr 16, 2018

Women remain less likely to receive high-intensity statins following heart attack

A recent study found that women are consistently less intensively treated with high-intensity statins after a heart attack, even when prescribed, and across various patient characteristics. This underutilization can lead to preventable vascular events, emphasizing the need for clinicians to communicate the benefits of these medications.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateApr 16, 2018

Hope for new treatment of severe epilepsy

Researchers at Lund University discovered a new approach to treat severe epilepsy by targeting a specific brain area, reducing seizure activity. This breakthrough method, using chemogenetics, may pave the way for improved treatment options for thousands of people in Sweden affected by the disease.

SourceLund University·JournalScientific Reports·DateApr 16, 2018